Homocysteine and DNA methylation: A review of animal and human literature

Molecular Genetics and Metabolism

Volumn 113, Issue 4, 2014, Pages 243-252

  Mandaviya, Pooja R ^a   Stolk, Lisette ^a   Heil, Sandra G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

B Vitamins; DNA methylation; Homocysteine; Hyperhomocysteinemia; S Adenosylhomocysteine; S Adenosylmethionine

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; DNA; FOLIC ACID; HOMOCYSTEINE; METHIONINE; METHIONINE SYNTHASE REDUCTASE; VITAMIN B GROUP; VITAMIN B COMPLEX;

BRAIN DISEASE; DIET SUPPLEMENTATION; DNA METHYLATION; GENE INACTIVATION; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY DISEASE; NEOPLASM; NONHUMAN; REVIEW; RIBOFLAVIN DEFICIENCY; VASCULAR DISEASE; ANIMAL; ANIMAL MODEL; BLOOD; CASE CONTROL STUDY; DIET; DIET THERAPY; FEMALE; MALE; METABOLISM; VITAMIN DEFICIENCY;

ANIMALIA;

ANIMALS; CASE-CONTROL STUDIES; DIET; DIETARY SUPPLEMENTS; DNA METHYLATION; FEMALE; FOLIC ACID; GENE KNOCKOUT TECHNIQUES; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHIONINE; MODELS, ANIMAL; VITAMIN B COMPLEX; VITAMIN B DEFICIENCY;

EID: 84918840941     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2014.10.006     Document Type: Review

References (100)

1. Selhub J. Homocysteine metabolism. Annu. Rev. Nutr. 1999, 19:217-246.
2. Boushey C.J., et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274(13):1049-1057.
3. van Meurs J.B., et al. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 2004, 350(20):2033-2041.
4. Fu W., et al. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochem. Biophys. Res. Commun. 2000, 271(1):47-53.
5. James S.J., et al. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 2002, 132(8 Suppl):2361S-2366S.
6. Selhub J., et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993, 270(22):2693-2698.
7. Mahalle N., et al. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease. J. Cardiol. 2013, 61(4):289-294.
8. Bergen N.E., et al. Homocysteine and folate concentrations in early pregnancy and the risk of adverse pregnancy outcomes: the Generation R Study. BJOG 2012, 119(6):739-751.
9. Zhang T., et al. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 2009, 12(5):680-686.
10. da Costa K.A., et al. Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am. J. Clin. Nutr. 2005, 81(2):440-444.
11. Chiuve S.E., et al. The association between betaine and choline intakes and the plasma concentrations of homocysteine in women. Am. J. Clin. Nutr. 2007, 86(4):1073-1081.
12. Chan J., et al. Low dietary choline and low dietary riboflavin during pregnancy influence reproductive outcomes and heart development in mice. Am. J. Clin. Nutr. 2010, 91(4):1035-1043.
13. van Meurs J.B., et al. Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease. Am. J. Clin. Nutr. 2013, 98(3):668-676.
14. Kang S.S., Wong P.W., Malinow M.R. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu. Rev. Nutr. 1992, 12:279-298.
15. Dayal S., et al. Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ. Res. 2001, 88(11):1203-1209.
16. Jiang Y., et al. Hyperhomocysteinemia-mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim. Biophys. Sin. 2007, 39(9):657-667.
17. Jiang Y., et al. The comprehensive effects of hyperlipidemia and hyperhomocysteinemia on pathogenesis of atherosclerosis and DNA hypomethylation in ApoE-/- mice. Acta Biochim. Biophys. Sin. 2012, 44(10):866-875.
18. Liu C., et al. Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine. J. Nutr. 2008, 138(2):311-315.
19. Ma S., et al. Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE(-/- ) mice. Acta Biochim. Biophys. Sin. 2013, 45(5):391-400.
20. Herrmann M., et al. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 2009, 44(3):467-475.
21. Obeid R., et al. Folate is related to phosphorylated neurofilament-H and P-tau (Ser396) in rat brain. J. Neurochem. 2011, 117(6):1047-1054.
22. Caudill M.A., et al. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 2001, 131(11):2811-2818.
23. Hirsch S., et al. Lack of effect of diet-induced hypomethylation on endothelium-dependent relaxation in rats. Clin. Nutr. 2008, 27(6):895-899.
24. McNeil C.J., et al. Differential effects of nutritional folic acid deficiency and moderate hyperhomocysteinemia on aortic plaque formation and genome-wide DNA methylation in vascular tissue from ApoE-/- mice. Clin. Epigen. 2011, 2(2):361-368.
25. McNeil C.J., et al. Nutritional B vitamin deficiency disrupts lipid metabolism causing accumulation of proatherogenic lipoproteins in the aorta adventitia of ApoE null mice. Mol. Nutr. Food Res. 2012, 56(7):1122-1130.
26. Blaise S., et al. Mild neonatal hypoxia exacerbates the effects of vitamin-deficient diet on homocysteine metabolism in rats. Pediatr. Res. 2005, 57(6):777-782.
27. Maloney C.A., Hay S.M., Rees W.D. Folate deficiency during pregnancy impacts on methyl metabolism without affecting global DNA methylation in the rat fetus. Br. J. Nutr. 2007, 97(6):1090-1098.
28. Mejos K.K., et al. Effects of parental folate deficiency on the folate content, global DNA methylation, and expressions of FRalpha, IGF-2 and IGF-1R in the postnatal rat liver. Nutr. Res. Pract. 2013, 7(4):281-286.
29. Mikael L.G., et al. Low dietary folate and methylenetetrahydrofolate reductase deficiency may lead to pregnancy complications through modulation of ApoAI and IFN-gamma in spleen and placenta, and through reduction of methylation potential. Mol. Nutr. Food Res. 2013, 57(4):661-670.
30. Partearroyo T., et al. Dietary folic acid intake differentially affects methionine metabolism markers and hippocampus morphology in aged rats. Eur. J. Nutr. 2013, 52(3):1157-1167.
31. Pogribny I.P., et al. Epigenetic alterations in the brains of Fisher 344 rats induced by long-term administration of folate/methyl-deficient diet. Brain Res. 2008, 1237:25-34.
32. Pogribny I.P., et al. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat. Res. 2006, 593(1-2):80-87.
33. Sontag E., et al. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J. Neurosci. 2007, 27(11):2751-2759.
34. Sohn K.J., et al. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis 2003, 24(1):81-90.
35. Duthie S.J., et al. Folate deficiency alters hepatic and colon MGMT and OGG-1 DNA repair protein expression in rats but has no effect on genome-wide DNA methylation. Cancer Prev. Res. 2010, 3(1):92-100.
36. Devlin A.M., et al. Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. Blood 2004, 103(7):2624-2629.
37. Chen Z., et al. Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet. 2001, 10(5):433-443.
38. Jadavji N.M., et al. Severe methylenetetrahydrofolate reductase deficiency in mice results in behavioral anomalies with morphological and biochemical changes in hippocampus. Mol. Genet. Metab. 2012, 106(2):149-159.
39. Choumenkovitch S.F., et al. In the cystathionine beta-synthase knockout mouse, elevations in total plasma homocysteine increase tissue S-adenosylhomocysteine, but responses of S-adenosylmethionine and DNA methylation are tissue specific. J. Nutr. 2002, 132(8):2157-2160.
40. Alberto J.M., et al. Mice deficient in cystathionine beta synthase display altered homocysteine remethylation pathway. Mol. Genet. Metab. 2007, 91(4):396-398.
41. Ikeda K., et al. Triacylglycerol/phospholipid molecular species profiling of fatty livers and regenerated non-fatty livers in cystathionine beta-synthase-deficient mice, an animal model for homocysteinemia/homocystinuria. Anal. Bioanal. Chem. 2011, 400(7):1853-1863.
42. Dayal S., et al. Cerebral vascular dysfunction in methionine synthase-deficient mice. Circulation 2005, 112(5):737-744.
43. Elmore C.L., et al. Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol. Genet. Metab. 2007, 91(1):85-97.
44. Padmanabhan N., et al. Mutation in folate metabolism causes epigenetic instability and transgenerational effects on development. Cell 2013, 155(1):81-93.
45. Devlin A.M., et al. Tissue-specific changes in H19 methylation and expression in mice with hyperhomocysteinemia. J. Biol. Chem. 2005, 280(27):25506-25511.
46. Glier M.B., et al. Tissue-specific relationship of S-adenosylhomocysteine with allele-specific H19/Igf2 methylation and imprinting in mice with hyperhomocysteinemia. Epigenet. 2013, 8(1):44-53.
47. Sulistyoningrum D.C., Singh R., Devlin A.M. Epigenetic regulation of glucocorticoid receptor expression in aorta from mice with hyperhomocysteinemia. Epigenet. 2012, 7(5):514-521.
48. Devlin A.M., et al. Hypermethylation of Fads2 and altered hepatic fatty acid and phospholipid metabolism in mice with hyperhomocysteinemia. J. Biol. Chem. 2007, 282(51):37082-37090.
49. Devlin A.M., et al. Hepatic acyl-coenzyme a:cholesterol acyltransferase-2 expression is decreased in mice with hyperhomocysteinemia. J. Nutr. 2010, 140(2):231-237.
50. Geisel J., et al. The vegetarian lifestyle and DNA methylation. Clin. Chem. Lab. Med. 2005, 43(10):1164-1169.
51. Melnyk S., et al. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5'-phosphate concentrations. Clin. Chem. 2000, 46(2):265-272.
52. Yi P., et al. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 2000, 275(38):29318-29323.
53. Perng W., et al. Dietary intake, plasma homocysteine, and repetitive element DNA methylation in the Multi-Ethnic Study of Atherosclerosis (MESA). Nutr. Metab. Cardiovasc. Dis. 2014, 24(6):614-622.
54. Farkas S.A., et al. Epigenetic alterations in folate transport genes in placental tissue from fetuses with neural tube defects and in leukocytes from subjects with hyperhomocysteinemia. Epigenet. 2013, 8(3):303-316.
55. Fryer A.A., et al. LINE-1 DNA methylation is inversely correlated with cord plasma homocysteine in man: a preliminary study. Epigenet. 2009, 4(6):394-398.
56. Fryer A.A., et al. Quantitative, high-resolution epigenetic profiling of CpG loci identifies associations with cord blood plasma homocysteine and birth weight in humans. Epigenet. 2011, 6(1):86-94.
57. Castro R., et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 2003, 49(8):1292-1296.
58. Sharma P., et al. Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol. 2008, 27(7):357-365.
59. Baccarelli A., et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology 2010, 21(6):819-828.
60. Huang Y.S., Zhi Y.F., Wang S.R. Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology 2009, 16(4):259-265.
61. Zhang D., et al. Homocysteine-related hTERT DNA demethylation contributes to shortened leukocyte telomere length in atherosclerosis. Atherosclerosis 2013, 231(1):173-179.
62. Kim C.S., et al. Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc. Cardiovasc. Res. 2011, 92(3):466-475.
63. Rodriguez-Esparragon F., et al. Homocysteinylated protein levels in internal mammary artery (IMA) fragments and its genotype-dependence. S-homocysteine-induced methylation modifications in IMA and aortic fragments. Mol. Cell. Biochem. 2012, 369(1-2):235-246.
64. Heil S.G., et al. DNA methylation status is not impaired in treated cystathionine beta-synthase (CBS) deficient patients. Mol. Genet. Metab. 2007, 91(1):55-60.
65. Pufulete M., et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology 2003, 124(5):1240-1248.
66. Al-Ghnaniem R., et al. Methylation of estrogen receptor alpha and mutL homolog 1 in normal colonic mucosa: association with folate and vitamin B-12 status in subjects with and without colorectal neoplasia. Am. J. Clin. Nutr. 2007, 86(4):1064-1072.
67. Van Guelpen B., et al. One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study. Cancer Causes Control 2010, 21(4):557-566.
68. Vasavi M., et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori 2006, 92(2):155-162.
69. Pirouzpanah S., et al. The effect of modifiable potentials on hypermethylation status of retinoic acid receptor-beta2 and estrogen receptor-alpha genes in primary breast cancer. Cancer Causes Control 2010, 21(12):2101-2111.
70. Naushad S.M., et al. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem. Biophys. 2014, 68(2):397-406.
71. Ingrosso D., et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003, 361(9370):1693-1699.
72. Nanayakkara P.W., et al. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease. Nephrol. Dial. Transplant. 2008, 23(8):2586-2592.
73. Hsu C.Y., et al. Global DNA methylation not increased in chronic hemodialysis patients: a case-control study. Ren. Fail. 2012, 34(10):1195-1199.
74. Selley M.L. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease. Neurobiol. Aging 2007, 28(12):1834-1839.
75. Bromberg A., et al. No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr. Res. 2008, 101(1-3):50-57.
76. Bromberg A., et al. Global leukocyte DNA methylation is not altered in euthymic bipolar patients. J. Affect. Disord. 2009, 118(1-3):234-239.
77. Kinoshita M., et al. Plasma total homocysteine is associated with DNA methylation in patients with schizophrenia. Epigenet. 2013, 8(6):584-590.
78. Friso S., et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(8):5606-5611.
79. Castro R., et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T and 1298A→C mutations are associated with DNA hypomethylation. J. Med. Genet. 2004, 41(6):454-458.
80. Shelnutt K.P., et al. Methylenetetrahydrofolate reductase 677C→T polymorphism affects DNA methylation in response to controlled folate intake in young women. J. Nutr. Biochem. 2004, 15(9):554-560.
81. Axume J., et al. The MTHFR 677TT genotype and folate intake interact to lower global leukocyte DNA methylation in young Mexican American women. Nutr. Res. 2007, 27(1):1365-1317.
82. Narayanan S., et al. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol. Biomarkers Prev. 2004, 13(9):1436-1443.
83. Hanks J., et al. The association between MTHFR 677C>T genotype and folate status and genomic and gene-specific DNA methylation in the colon of individuals without colorectal neoplasia. Am. J. Clin. Nutr. 2013, 98(6):1564-1574.
84. Pufulete M., et al. Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. Br. J. Cancer 2005, 92(5):838-842.
85. Achon M., et al. Supranormal dietary folic acid supplementation: effects on methionine metabolism in weanling rats. Br. J. Nutr. 2007, 98(3):490-496.
86. Min H. Effects of dietary supplementation of high-dose folic acid on biomarkers of methylating reaction in vitamin B(12)-deficient rats. Nutr. Res. Pract. 2009, 3(2):122-127.
87. Sie K.K., et al. Effect of maternal and postweaning folic acid supplementation on global and gene-specific DNA methylation in the liver of the rat offspring. Mol. Nutr. Food Res. 2013, 57(4):677-685.
88. Sie K.K., et al. Effect of maternal and postweaning folic acid supplementation on colorectal cancer risk in the offspring. Gut 2011, 60(12):1687-1694.
89. Kalani A., et al. Nutri-epigenetics ameliorates blood-brain barrier damage and neurodegeneration in hyperhomocysteinemia: role of folic acid. J. Mol. Neurosci. 2014, 52(2):202-215.
90. Pufulete M., et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut 2005, 54(5):648-653.
91. Al-Ghnaniem Abbadi R., Emery P., Pufulete M. Short-term folate supplementation in physiological doses has no effect on ESR1 and MLH1 methylation in colonic mucosa of individuals with adenoma. J. Nutrigenet. Nutrige. 2012, 5(6):327-338.
92. van den Donk M., et al. Folic acid and vitamin B-12 supplementation does not favorably influence uracil incorporation and promoter methylation in rectal mucosa DNA of subjects with previous colorectal adenomas. J. Nutr. 2007, 137(9):2114-2120.
93. Pizzolo F., et al. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. J. Am. Coll. Nutr. 2011, 30(1):11-18.
94. Stopper H., et al. Reduction of the genomic damage level in haemodialysis patients by folic acid and vitamin B12 supplementation. Nephrol. Dial. Transplant. 2008, 23(10):3272-3279.
95. Hubner U., et al. Effect of 1year B and D vitamin supplementation on LINE-1 repetitive element methylation in older subjects. Clin. Chem. Lab. Med. 2013, 51(3):649-655.
96. Green T.J., et al. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations. Br. J. Nutr. 2010, 103(11):1629-1634.
97. Jung A.Y., et al. No effect of folic acid supplementation on global DNA methylation in men and women with moderately elevated homocysteine. PLoS One 2011, 6(9):e24976.
98. Bae S., et al. Impact of folic acid fortification on global DNA methylation and one-carbon biomarkers in the Women's Health Initiative Observational Study cohort. Epigenet. 2014, 9(3):396-403.
99. Barault L., et al. Leukocyte DNA as surrogate for the evaluation of imprinted Loci methylation in mammary tissue DNA. PLoS One 2013, 8(2):e55896.
100. Ashbury J.E., et al. Biomarkers measured in buccal and blood leukocyte DNA as proxies for colon tissue global methylation. Int. J. Mol. Epidemiol. Genet. 2014, 5(2):120-124.